Evidence map›Paper›PMID 32937647›Full record

ArticlePediatric research2021

Bronchopulmonary dysplasia precursors influence risk of white matter injury and adverse neurodevelopmental outcome in preterm infants.

Kimberly N Grelli, Roberta L Keller, Elizabeth E Rogers, J Colin Partridge, Duan Xu, A James Barkovich, Dawn Gano

Open access · greenAbstract read
In one paragraph

Article in Pediatric research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 29 citations in OpenAlex.

  1. Beyond Histamine Blockade: Clemastine Fumarate as a Promoter of Myelin Regeneration, Inflammatory Regulation, and Neuroimmune Modulation in CNS Disorders.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026
    Review
  2. Article
  3. Article
  4. Early medical risks to language development in extremely preterm infants.Journal of perinatology : official journal of the California Perinatal Association · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kimberly N GrelliDepartment of Pediatrics, University of California, San Francisco, San Francisco, CA, USA.
Roberta L KellerDepartment of Pediatrics, University of California, San Francisco, San Francisco, CA, USA.
Elizabeth E RogersDepartment of Pediatrics, University of California, San Francisco, San Francisco, CA, USA.
J Colin PartridgeDepartment of Pediatrics, University of California, San Francisco, San Francisco, CA, USA.
Duan XuDepartment of Radiology, University of California, San Francisco, San Francisco, CA, USA.
A James BarkovichDepartment of Radiology, University of California, San Francisco, San Francisco, CA, USA.
Dawn GanoDepartment of Pediatrics, University of California, San Francisco, San Francisco, CA, USA. dawn.gano@ucsf.edu.
University of California, San Francisco · US

Funding

White matter injury as predictor of outcome in neonatal brain injuryP50NS035902 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIERO, DONNA M. · 1997 to 2012
$14.0M
Development of Advanced Techniques for MR of the Newborn BrainR01EB009756 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BARKOVICH, ANTHONY JAMES, XU, DUAN · 2009 to 2013
$5.5M
MRI, MRSI, AND DTI OF BRAIN INJURY IN PRETERM NEONATESR01NS046432 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BARKOVICH, ANTHONY JAMES · 2004 to 2013
$4.3M
NIBIB NIH HHS R01 EB009756NINDS NIH HHS P50 NS035902NINDS NIH HHS R01 NS046432
6 · The paper itself

Abstract

backgroundCumulative supplemental oxygen (CSO) and cumulative mean airway pressure (CMAP) are associated with bronchopulmonary dysplasia (BPD) in preterm infants, but their relationships to white matter injury (WMI) and neurodevelopment have not been evaluated.

methodsPreterm infants <32 weeks' gestation were prospectively imaged with 3 T MRI near term. CSO and CMAP were retrospectively summed over the first 14 and 28 days. Neurodevelopment was assessed at 30 months adjusted using the Bayley-III. ROC and linear regression were used to evaluate the relationship between CSO, CMAP, and BPD with WMI and neurodevelopmental performance, respectively.

resultsOf the 87 infants, 30 (34.5%) had moderate-severe BPD, which was associated with WMI (OR 5.5, 95% CI 1.1-34.9, p = 0.012). CSO and CMAP predicted WMI as well as BPD (AUC 0.68-0.77). CSO was independently associated with decreased language and cognitive performance (mean difference at 14 days: -11.0, 95% CI -19.8 to -2.2, p = 0.015 and -9.8, 95% CI -18.9 to -0.7, p = 0.035, respectively) at 30 months adjusted.

conclusionsBPD precursors predict WMI as well as BPD. Cumulative supplemental oxygen over the first 14 days of life is independently associated with lower language and cognitive performances. These data suggest that early respiratory status influences the risk of adverse neurodevelopment in preterm infants. IMPACT: Respiratory precursors to bronchopulmonary dysplasia (BPD), cumulative supplemental oxygen and mean airway pressure, over the first 14-28 days performed as well as BPD for the prediction of white matter injury on MRI in preterm infants. Cumulative supplemental oxygen was independently associated with lower language and cognitive performance on the Bayley-III at 30 months adjusted. These data suggest that early respiratory status may help explain why BPD is independently associated with adverse neurodevelopmental outcomes in the preterm population and highlights the importance of interventions targeting respiratory status as a potential avenue to improve neurodevelopmental outcomes.

Indexed as

Child DevelopmentRespirationAge FactorsBronchopulmonary DysplasiaChild LanguageChild, PreschoolCognitionCross-Sectional StudiesGestational AgeHumansInfant, NewbornInfant, PrematureLeukoencephalopathiesLungMagnetic Resonance ImagingMotor Activity

Identifiers

PMID32937647
PMCPMC7960569
OpenAlexW3087591451

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.